Skip to content
Armando Hasudungan

Major Depressive Disorder

DSM V categorise these as seperate disorders

  • Depressive disorders
  • Bipolar disorders
  • Anxiety disorders

Depressive Disorders

  • Major depressive disorder
  • Other depressive disorder
    • Persistent Depressive Disorder
    • Substance/medication induced depression disorder
    • Depressive disorder due to another medical condition

Overview

Depressive disorders are typically characterised by persistent low mood, loss of interest and enjoyment, neurovegetative disturbance, and reduced energy, causing varying levels of social and occupational dysfunction. Depression is the leading cause of disability and premature death in 18-44 yo and is predicated to be the 2nd leading cause of disability in 2020.  20% of adults will have it at some point in their life, women are twice as likely. Depression will make up ~5-10% of people seen in primary care setting.

Definition

Anhedonia: Loss of interest or pleasure in activities that were previously pleasurable
Depression: Clinical Depression is an illness, a medical condition. It significantly affects the way someone feels, causing a persistent lowering of mood.
Grief: 
Multifaceted response to loss, particularly to the loss of someone or something that has died, to which a bond or affection was formed.

Grief Depression
There is an identifiable lossA specific loss may or may not be identified
The person’s focus is on the lossThe person’s focus is on self
Fluctuating ability to feel pleasureInability to feel pleasure
Fluctuating physical symptomsProlonged and marked functional impairment
Closeness of others is usually comfortingPersistent isolation from other and self
Able to feel a wide range of emotionsFixed emotions and feeling “stuck”
May express guilt over some aspects over lossGeneralised feelings of guilt
Thoughts of death are typically related to wanting to be reunited with the deceased loved oneThoughts of death related to feeling worthless, undeserving of life or unable to cope with the pain

Aetiology & Risk Factors

Aetiology

Multifactorial

Changes in brain

  • No structural abnormalities
  • Function abnormalities present:
    • Decreased activity in frontal lobe
    • Increased firing in the limbic system
    • Increase cortisol in blood
    • Altered neurotransmitter pathways
      • Serotonin
      • Dopamine
      • Noradrenaline

Risk Factors

Risk Factors
Age (onset peaks in late 20s)
Family history (3x risk with affected 1° relatives)
Personal history
Lower SES
Substance abuse
Adverse life events
Lack of confiding relationship
Physical illness

Clinical Manifestations

1/1

Mneumonic SIG-E-CAPS for the signs and symptoms of Depression.

  • Sleep changes
  • Interest (decreased)
  • Guilt (excessive)
  • Energy (decreased)
  • Concentration (decreased)
  • Appetite changes
  • Psychomotor agitation or retardation
  • Suicidal ideation

Non-specific symptoms of Depression

Differential Diagnosis

  • Bipolar Disorder
  • Grief reaction
  • Anxiety
  • Hypothyroidism
  • Multiple Sclerosis
  • Dementia
  • Other depressive disorder
    • Persistent Depressive Disorder
    • Substance/medication induced depression disorder (illicit drug withdrawal, antihypertensives, steroids)
    • Depressive disorder due to another medical condition

Rule out an underlying substance (eg, alcohol and cocaine withdrawal), medication (eg, antihypertensives, steroids), or medical condition causing depression (eg, hypothyroidism, multiple sclerosis), especially if the patient does not have a prior history of depression.

Investigations

  • FBC (anaemia, infectious diseases)
  • ESR
  • EUC
  • LFT
  • Urinalysis – uraemia
  • Thyroid function tests – hypothyroidism
  • ECG – dysrhythmia -> cerebral infarct

Diagnosis

  • 1 core symptom
  • At least 4 associated symptoms (SIG-E-CAPS)
    • Sleep changes
    • Interest (decreased)
    • Guilt (excessive)
    • Energy (decreased)
    • Concentration (decreased)
    • Appetite changes
    • Psychomotor agitation or retardation
    • Suicidal ideation

Criteria for symptoms

  • Pervasive (all day, most days)
  • Persistent (2 weeks)
  • Not better explained
  • No manic or hypomanic episodes
  • New signs and symptoms then normal that impact with daily function

Treatment

The treatment that was successful for prior episodes of major depression has a higher likelihood of achieving remission in future episodes.

Psychological therapy

  • Cognitive behavioural therapy
  • Interpersonal therapy

Psychosocial treatments are first line treatments for mild depression. Usually psychotherapy is used in conjunction with pharmacotherapy.

Pharmacological therapy 

  • SSRI (first line)
    • Certraline
  • SNRI
    • Desvanlafaxine
  • TCA
    • Amytriptaline
  • Other

None has been shown to be more effective then the other, so the choice depends on the adverse effects the patient can tolerate. SNRI are used first line because they generally have less side effects. When response to treatment is poor the diagnosis and compliance with treatment should be reassessed

important to identify if patient also has manic episodes in the past, as antidepressent can induce a manic episode.

Adults with major depressive disorder being treated with antidepressants should be observed for worsening depressed mood and suicidality, especially during the initial few months of a course of drug therapy, or at times of dose changes (either increases or decreases).

Pharmacology

Selective serotonin reuptake inhibitors  (SSRI) work by inhibiting the reuptake of serotonin from the synativ cleft thus increase serotonin effects on post synaptic neurons (causing good feels). Lower starting doses are often recommended and slowly increase and titrate accordingly. Side effects: Diarrhea, dizziness, dry mouth, fatigue, headache, sexual dysfunction, sweating, tremor, and weight gain are commonly reported. Nausea and vomiting are the most common reasons for discontinuation. Overdose of SSRI leads to serotonin syndrome (more info below).

Moderate/severe depression:

  • Electro Convulsive Therapy
  • Transcranial Magnetic Stimulation

Complications & Prognosis

Complications

  • Sexual dysfunction and Gastrointestinal disturbance of SSRIs and SNRIs
  • Risk of self-injurious behaviour
  • Undesired weight gain from antidepressant

Risk of suicide with SSRI (increase risk in young, risk decreases in old >25years).

Prognosis

  • Complete remission of symptoms and return to normal functioning are the therapy goals.
  • For patients in their first episode of depression, treatment to remission may take up to several months and should be continued for a minimum of 9 to 12 months after remission.
  • For patients who have had recurrent episodes, or in whom relapse or recurrence would likely convey a high risk, evidence supports prolonged antidepressant treatment.

More than 50% of patients who have had one episode of major depression will have recurrent episodes.

Postpartum Depression

Many experience what is known as postpartum blues, in which there is sadness, strong feelings of dependency, frequent crying spells, and dysphoria. This occurs in up to one in seven women.

Postpartum blues usually last for several days to a week. In rare cases, postpartum depression exceeds in both severity and length that is observed in postpartum blues and is characterized by suicidality and severely depressed feelings.

All women should be screened for depression during pregnancy and the postpartum period.

Risk factors

  • History of depression
  • Family history
  • Mental illness
  • Recent stressful life events
  • Poor social support
  • Discontinuing pharmaceutical treatments
  • Exposure to violence

Diagnosis

Management

For first-time mothers, adolescent mothers, and mothers who have experienced a traumatic delivery, home health visits, telephone-based peer support, and psychotherapy may help prevent peripartum depression.

  • Mild to moderate depression – psychotherapy or selective serotonin reuptake inhibitors (SSRI’s)
  • Moderate to severe depression – combination of psychotherapy and medication (SSRI’s are the safest)

Serotonin Syndrome

Selective serotonin reuptake inhibitors are the most commonly used medications for depression but should not be used in conjunction with MAOIs. One medication should be discontinued for at least 5 weeks before the other is initiated to avoid serotonin syndrome.

Serotonin syndrome is characterized by (in order of appearance) diarrhea, restlessness, extreme agitation, hyperreflexia, autonomic instability, myoclonus, seizures, hyperthermia, rigidity, delirium, coma, and death.

Discussion

Members only discussions coming soon…

On this page

Quiz

This quiz is included in our Question Bank

  • Test your knowledge with thousands of MCQs

  • Customise your own quiz sets

Get your membership to access

Take note

Note taking is a member feature

  • Record notes on any page

  • Access and download all notes in your notes folder

Get your membership to access

Bookmark lists

Bookmark lists is a member feature

  • Save your favourite posts to lists

  • Create, customise, and share as many lists as you want

  • Use lists for personalised lesson plans

  • Structure your lists as Pathways, playlists, or even design your own quizzes

Get your membership to access

Feedback

Members keep our quality high

  • Suggest edits if you find inaccuracies or areas of improvement

  • Request content if you find a gap in our knowledge base

Get your membership to access